Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.

Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K.

Eur J Surg Oncol. 1988 Oct;14(5):407-12.

PMID:
3181444
2.

Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer.

Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV.

Br J Surg. 1985 May;72(5):365-7.

PMID:
3995243
3.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
4.

Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.

Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):658-70.

PMID:
12788171
5.

Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone.

Galper S, Recht A, Silver B, Manola J, Gelman R, Schnitt SJ, Connolly JL, Harris JR.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1157-66.

PMID:
10613308
6.

Treatment of the axilla in early breast cancer: past, present and future.

Chua B, Ung O, Boyages J.

ANZ J Surg. 2001 Dec;71(12):729-36.

PMID:
11906388
7.

Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.

Voogd AC, de Boer R, van der Sangen MJ, Roumen RM, Rutten HJ, Coebergh JW.

Eur J Surg Oncol. 2001 Apr;27(3):250-5.

PMID:
11373100
8.

[Axillary dissection in primary surgical treatment of breast cancer: risk of false-negative axillary status].

Graversen HP, Zedeler K, Andersen JA, Axelsson CK, Blichert-Toft M.

Ugeskr Laeger. 1992 Nov 23;154(48):3392-5. Danish.

PMID:
1462447
9.

[Management of the axilla in breast cancer: evidences and unresolved issues].

Fodor J, Polgár C, Péley G, Németh G.

Orv Hetil. 2001 Sep 9;142(36):1941-50. Review. Hungarian.

PMID:
11680099
10.

Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.

Mignano JE, Zahurak ML, Chakravarthy A, Piantadosi S, Dooley WC, Gage I.

Cancer. 1999 Oct 1;86(7):1258-62.

PMID:
10506712
11.

Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):883-94.

PMID:
10863056
12.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
13.

Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.

Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA.

Ann Surg Oncol. 1998 Mar;5(2):140-9.

PMID:
9527267
14.

Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, Stitt L, Radwan JS.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9.

PMID:
9231679
15.
16.
17.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Stitt L.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):117-23.

PMID:
9747828
18.

Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2002 Nov;72(11):786-92.

PMID:
12437688
20.

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.

White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.

J Am Coll Surg. 1996 Dec;183(6):575-82.

PMID:
8957459

Supplemental Content

Support Center